Aldeyra Therapeutics Inc. (ALDX)

NASDAQ: ALDX · Real-Time Price · USD

2.85

0.14 (5.17%)

At close: May 02, 2025, 3:19 PM

Aldeyra Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	262.78K	258.71K	264.18K	56.22K	96.31K	71K	37.85K	35.79K
Gross Profit	n/a	-262.78K	-258.71K	-264.18K	-56.22K	-96.31K	-71K	-37.85K	-35.79K
Operating Income	-60.12M	-42.79M	-62.68M	-56.22M	-36.42M	-63.07M	-39.7M	-22.49M	-18.7M
Interest Income	6.19M	7.32M	2.35M	185.36K	292.22K	1.54M	952.7K	261.25K	102.04K
Pretax Income	-55.85M	-37.54M	-62.02M	-57.78M	-38.03M	-62.14M	-38.89M	-22.34M	-18.7M
Net Income	-55.85M	-37.54M	-61.37M	-59.25M	-37.55M	-60.83M	-38.89M	-22.34M	-18.7M
Selling & General & Admin	11.89M	13.34M	15.37M	11.28M	9.99M	12.15M	9.88M	6.19M	5.52M
Research & Development	48.22M	29.46M	47.31M	44.94M	24.68M	44.35M	29.82M	16.3M	13.18M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	60.12M	42.79M	62.68M	56.22M	34.67M	56.51M	39.7M	22.49M	18.7M
Interest Expense	-1.93M	2.07M	1.69M	1.74M	1.9M	603.85K	146.79K	113.45K	105.51K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	42.79M	62.68M	56.22M	34.67M	56.51M	39.7M	22.49M	18.7M
Income Tax Expense	n/a	n/a	-655.35K	1.48M	-479.26K	-1.31M	952.7K	223.4K	66.25K
Shares Outstanding (Basic)	59.48M	58.94M	58.41M	54.04M	33.97M	27.11M	21.69M	15.92M	11.35M
Shares Outstanding (Diluted)	59.48M	58.94M	58.41M	54.04M	33.97M	27.11M	21.69M	15.92M	11.35M
EPS (Basic)	-0.94	-0.64	-1.05	-1.1	-1.11	-2.24	-1.79	-1.4	-1.65
EPS (Diluted)	-0.94	-0.64	-1.05	-1.1	-1.11	-2.24	-1.79	-1.4	-1.65
EBITDA	-60.12M	-35.21M	-60.07M	-55.77M	-36.07M	-61.44M	-38.68M	-22.19M	-18.56M
EBIT	-57.78M	-35.47M	-60.33M	-56.03M	-36.13M	-61.53M	-38.75M	-22.23M	-18.59M
Depreciation & Amortization	-2,339.3B	262.78K	258.71K	264.18K	56.22K	96.31K	71K	37.85K	35.79K